ID: ALA3765811

Max Phase: Preclinical

Molecular Formula: C13H17IN2O

Molecular Weight: 344.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccccc1I)NC1CCCCC1

Standard InChI:  InChI=1S/C13H17IN2O/c14-11-8-4-5-9-12(11)16-13(17)15-10-6-2-1-3-7-10/h4-5,8-10H,1-3,6-7H2,(H2,15,16,17)

Standard InChI Key:  MBXJHHNPQZHJBV-UHFFFAOYSA-N

Associated Targets(non-human)

3T3-L1 3664 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 344.20Molecular Weight (Monoisotopic): 344.0386AlogP: 3.75#Rotatable Bonds: 2
Polar Surface Area: 41.13Molecular Species: NEUTRALHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.44CX Basic pKa: CX LogP: 3.83CX LogD: 3.83
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.79Np Likeness Score: -1.65

References

1. Blöcher R, Lamers C, Wittmann SK, Merk D, Hartmann M, Weizel L, Diehl O, Brüggerhoff A, Boß M, Kaiser A, Schader T, Göbel T, Grundmann M, Angioni C, Heering J, Geisslinger G, Wurglics M, Kostenis E, Brüne B, Steinhilber D, Schubert-Zsilavecz M, Kahnt AS, Proschak E..  (2016)  N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators.,  59  (1): [PMID:26595749] [10.1021/acs.jmedchem.5b01239]

Source